Speaker illustration

undefined undefined undefined

Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland

Event: ESC Congress 2022

Topic: Secondary Prevention

Session: Secondary prevention 2

Thumbnail

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Event: ESC Congress 2020

Topic: Public Health

Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?

Thumbnail

ESC 365 is supported by